|
|
 |
| |
|
Home > Drug Companies > Sankyo Pharma, Inc.
Sankyo Pharma, Inc.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
The union of Daiichi and Sankyo brings together two pharmaceutical companies bound by a century of vision and a legacy of firsts. They believe good science walks hand in hand with humanity and, as they move forward into their next century, Daiichi Sankyo seeks to build on their history of discovery with the development of new therapies in cardiovascular disease, cancer, metabolic disorders, and infection.
To their employees, they offer an operational structure that balances creativity with discipline and individualism with collaboration. They balance the strength and stability of their global presence with the spirit, agility, and quick reaction times of much smaller companies.
Theirs is an entrepreneurial spirit, grounded by a dedication to improving the lives of each patient. They create success through solid science and a commitment to add to the balance of life in each of their endeavors. Their shared values provide the foundation for achieving these goals. They harness the spirit of the individual by providing the training, tools, and technology necessary. for individual growth, while offering a solid foundation of support through teamwork and a highly collaborative work environment.
The Company’s behavior is grounded on the basic principles of ethical behavior in telling the truth, keeping your word, respecting the rights of others and following the law. This commitment is unwavering and extends to their contractors, consultants, and suppliers.
Back to Drug Companies
|
|
|
|
|
|
|
|